UBM Pharma Portfolio Will Debut CPhI Southeast Asia 2012 in Jakarta

April 22, 2012

UBM continues to expand its worldwide portfolio adding to UBM Live’s Pharma division a new show, CPhI Southeast Asia 2012, which will focus on the pharmaceutical ingredient sector in the ASEAN region.

 

The show will debut May 10-12 at the Jakarta International Expo in Indonesia.

 

"The ASEAN pharma market represents huge potential for companies looking to expand operations. Notably, there is strong interest in R&D for generics in this region, which are expected to grow from 8.3 percent of the total market in 2010 to 12.8 percent by 2015, when they will be worth USD $12.3 billion," said Andrew Pert, UBM Live Regional Director.

 

He added, "Beyond generics, the Indonesian Pharmaceutical Association, GP Farmasi, forecasts a market value of USD 4.9 billion in 2012 which represents an increase of 10-12% year over year(1). The growth rate is phenomenal and UBM Live is pleased to debut CPhI Southeast Asia in 2012 to support this emerging market."

 

Several high profile international pharma firms are on tap to exhibit, including Boehringer Ingelheim, Phapros, and the Mensa Group, along with exhibitors in the steadily growing natural extract sector such as Javaplant and Semarang Herbal.

 

The event also will have support from international organizations Pharmexcil India, the China Council for the Promotion of International Trade (CCPIT) and the China Chamber of Commerce for Import & Export of Medicine and Health Products (CCCMHPIE).

 

A rise in the standard of living in Indonesia has created strong growth in the pharmaceutical market, according to UBM officials.

 

The growth has also impacted the import value of pharmaceutical raw materials, which is projected to reach up to USD $1.39 billion this year, about 11 to 15 percent higher than last year, according to a recent article in Indonesia Finance Today.

 

The event will feature a zoned format that will make it easy to navigate, with zones for APIs, intermediates, natural extracts, biopharmaceuticals, custom manufacturing, fine chemicals, excipients/formulations and a general zone for the crossover between the different zones.

 

There also will be international pavilions for attendees visiting from across the globe and more specifically the China and India Pavilions will offer contact with partners in the greater Asia pharmaceutical market. 

 

Other shows scheduled in UBM Live’s portfolio include ICSE USA May 22-23 at the Pennsylvania Convention Centre in Philadelphia,  CPhI, ICSE, P-MEC InnoPack and BioPh China June 26-28 at the SNIEC in Shanghai and CPhI, ICSE and BioPh South America Aug. 21-23 at the Transamerica Expo Center in Sao Paulo.

 

Add new comment

Partner Voices
MGM Resorts is committed to fostering an inclusive and diverse culture, not just among employees and guests but also within its supply chain. The company prioritizes procuring goods and services from businesses owned by minorities, women, veterans, people with disabilities, LGBTQ individuals and those facing economic disadvantages. This commitment is integral to MGM Resorts' global procurement strategy.    Through its voluntary supplier diversity program, MGM Resorts actively identifies and connects certified diverse-owned suppliers to opportunities within its supply chain. The company is on track to spend at least 15% of its biddable procurement with diverse-owned businesses by 2025, demonstrating that supplier diversity is not only a social responsibility but also a strategic business imperative.    Supplier diversity isn’t just the right thing to do – it’s good for business. A diverse supply chain allows access to a broader range of perspectives and experience, helping to drive innovation, entrepreneurship and resilience, while strengthening communities. At MGM Resorts, engaging diverse suppliers ensures best-in-class experiences for guests and clients. Supplier diversity ensures a more resilient supply chain while supporting economic development in the communities in which it operates.   The impact of MGM Resorts' supplier diversity initiatives is significant. In 2023, these efforts supported over 3,500 jobs across more than 30 states, contributed over $214 million in income for diverse-owned businesses and generated more than $62 million in tax revenue. The story extends beyond the numbers – it reflects the tangible benefits brought to small and diverse-owned businesses, fostering economic empowerment in their communities.    MGM Resorts also supports the development and business skills of diverse-owned businesses through investment, mentorship and education. Through the MGM Resorts Supplier Diversity Mentorship Program, the company identifies, mentors and develops diverse-owned businesses to fill its future pipeline, while providing businesses with tools and resources to empower and uplift. Since 2017, the program has successfully graduated 105 diverse-owned businesses and is on track to achieve its goal of 150 graduates by 2025.     MGM Resorts’ commitment to supplier diversity not only enhances its business operations but also plays a crucial role in uplifting communities and fostering economic development. This approach reinforces the idea that diversity is a powerful driver of innovation and resilience, benefiting both the company and the wider community.